Search

everythinglearnresearchcommunity

for

Search:↓

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Changing neuroactive steroids in baby male rats affects their memory and learning differently as they grow up.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Ptprq has multiple forms that change during inner ear development.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

The chitosan/PDRN polyplex improved wound healing in diabetic rats.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

PP405 may help hair growth by activating hair follicle stem cells.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

DHT is needed for long-term depression, while E2 is needed for full long-term potentiation in male rat brains.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

GI197111X is best dissolved in Capmul MCM for trials.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.